· 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y...

14

Transcript of  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y...

Page 1:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 2:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 3:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 4:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 5:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 6:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 7:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 8:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 9:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 10:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 11:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 12:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 13:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa
Page 14:  · 2016-01-11 · v/ HA3HB (ÞAKYJITETA OaK.YJITeT nexar011JKHx Ha.YKa YHHBep3HTe-ra y Kpary.jeBu.y H3BEUITAJ 011PUJABJbEHHM HA ROHRYPC 3A U3bOP Y HACTABHURA - 06aBe3Ha canp)KHHa

Peri-procedural Management of Patients undergoing …canpweb.org/canp/assets/File/2014 Conference Presentations/Peri-procedural.pdfPeri-procedural Management of Patients undergoing

Peri-procedural Management of Patients undergoing …canpweb.org/canp/assets/File/2014 Conference Presentations/Peri-procedural.pdfPeri-procedural Management of Patients undergoing

Pharmacotherapy for Chronic Pain Management - CANPcanpweb.org/canp/assets/File/2014 Conference Presentations... · •Review Chronic Pain •Discuss Challenges in Providing Chronic

Pharmacotherapy for Chronic Pain Management - CANPcanpweb.org/canp/assets/File/2014 Conference Presentations... · •Review Chronic Pain •Discuss Challenges in Providing Chronic

o dodeli...Ha3HB H anpeca 110Hybaqa Bpoj H aaTYM KOjHM je r10HYžaa 3aBeneHa KOA ITOH aga YKyr1Ha 110HYbeHa ueHa 6e3 IlÅB-a POK 3aBPL1_1eTKa paA0Ba (MaKCHMaJIHH POK 3a gaBP111eTaK

o dodeli...Ha3HB H anpeca 110Hybaqa Bpoj H aaTYM KOjHM je r10HYžaa 3aBeneHa KOA ITOH aga YKyr1Ha 110HYbeHa ueHa 6e3 IlÅB-a POK 3aBPL1_1eTKa paA0Ba (MaKCHMaJIHH POK 3a gaBP111eTaK

Migraine: Updates in Diagnosis & Treatmentcanpweb.org/canp/assets/File/2015 Conference...pharmacological treatments while evaluating side effects and efficacy. • Evaluate non-pharmacological

Migraine: Updates in Diagnosis & Treatmentcanpweb.org/canp/assets/File/2015 Conference...pharmacological treatments while evaluating side effects and efficacy. • Evaluate non-pharmacological

Treating Substance Abuse in the Primary Care Setting - …canpweb.org/canp/assets/File/2014 Conference Presentations... · Maladaptive pattern of use, ... – Assessment, evaluation

Treating Substance Abuse in the Primary Care Setting - …canpweb.org/canp/assets/File/2014 Conference Presentations... · Maladaptive pattern of use, ... – Assessment, evaluation

CANADIAN ASSOCIATION OF …neuro.pathology.pitt.edu/canp/CANPCases2011/CANPCase... · Web viewCongenital heart disease was characterized by “mirror image branching of the aorta”

CANADIAN ASSOCIATION OF …neuro.pathology.pitt.edu/canp/CANPCases2011/CANPCase... · Web viewCongenital heart disease was characterized by “mirror image branching of the aorta”

Equianalgesic Dosing It’s not just about the math - CANPcanpweb.org/canp/assets/File/2014 Conference Presentations... · Equianalgesic Dosing It’s not just about ... Elimination

Equianalgesic Dosing It’s not just about the math - CANPcanpweb.org/canp/assets/File/2014 Conference Presentations... · Equianalgesic Dosing It’s not just about ... Elimination

The Fibromyalgia Syndrome: Updates in Diagnosis ...canpweb.org › canp › assets › File › 2015 Conference Presentations › … · •2-6% US population, women>men 7:1 • Average

The Fibromyalgia Syndrome: Updates in Diagnosis ...canpweb.org › canp › assets › File › 2015 Conference Presentations › … · •2-6% US population, women>men 7:1 • Average

Geriatric Depression and Anxiety - California Association …canpweb.org/canp/assets/File/2015 Conference... ·  · 2016-02-29Geriatric Depression and Anxiety . Jennifer Serafin

Geriatric Depression and Anxiety - California Association …canpweb.org/canp/assets/File/2015 Conference... ·  · 2016-02-29Geriatric Depression and Anxiety . Jennifer Serafin

95.43.208.10395.43.208.103/wp-content/uploads/2016/10/techni4esko.pdfRpwrepHHTe Ha cnpaBRaTa: 11bJ1>KHHa Ha Kopa6HTe B Me-rpH C TOHHOCT ao BTOPH¶T aeceT1,1t1eH 3HaK (LIPIdMEP 5,99);

95.43.208.10395.43.208.103/wp-content/uploads/2016/10/techni4esko.pdfRpwrepHHTe Ha cnpaBRaTa: 11bJ1>KHHa Ha Kopa6HTe B Me-rpH C TOHHOCT ao BTOPH¶T aeceT1,1t1eH 3HaK (LIPIdMEP 5,99);

Understanding Michael Loughran Nursecanpweb.org/canp/assets/File/2013 Conference... · Michael Loughran Robin Burroughs 3 Claims Study What we Considered • Inclusion criteria (applied

Understanding Michael Loughran Nursecanpweb.org/canp/assets/File/2013 Conference... · Michael Loughran Robin Burroughs 3 Claims Study What we Considered • Inclusion criteria (applied

Advocating for Nurse Practitioners and their patients Nurse Practitioner Students: Helping CANP Grow.

Advocating for Nurse Practitioners and their patients Nurse Practitioner Students: Helping CANP Grow.

Governor’s Office for Children and Families Child Abuse and Neglect Prevention Programs (CANP) – Direct Services Grant Administration Overview.

Governor’s Office for Children and Families Child Abuse and Neglect Prevention Programs (CANP) – Direct Services Grant Administration Overview.

Tic Disorders in Children - canpweb.orgcanpweb.org/canp/assets/File/2013 Conference... · 22.03.2013  · Transient Tic Disorder DSM-IV-TR, 2000 Classification • Motor Tic + Vocal

Tic Disorders in Children - canpweb.orgcanpweb.org/canp/assets/File/2013 Conference... · 22.03.2013  · Transient Tic Disorder DSM-IV-TR, 2000 Classification • Motor Tic + Vocal

Evaluation of Thyroid Nodules in Primary Care - CANP Conference Presentations... · Design an initial diagnostic plan of care ... total thyroidectomy, taking levothyroxine : ... Evaluation

Evaluation of Thyroid Nodules in Primary Care - CANP Conference Presentations... · Design an initial diagnostic plan of care ... total thyroidectomy, taking levothyroxine : ... Evaluation

apotekanis · 1003. 04.12.2018 y 12.00 can-I 1004. 05.12.2018. roa y 09.00 caTV1 1005. 05.12.2018. roa y 09.10 caTV1 1006. 05.12.2018 roa y 09.15 caTV1 Ha3HB noHYhaqa „Magna Pharmacia"

apotekanis · 1003. 04.12.2018 y 12.00 can-I 1004. 05.12.2018. roa y 09.00 caTV1 1005. 05.12.2018. roa y 09.10 caTV1 1006. 05.12.2018 roa y 09.15 caTV1 Ha3HB noHYhaqa „Magna Pharmacia"

DISORDERS OF THE CERVICAL SPINE - CANP Conference Presentations...Herniated Nucleus Pulposus (HNP) . Mechanical Contributors to Cervical Spine Disorders . Definitions: - spondylo =

DISORDERS OF THE CERVICAL SPINE - CANP Conference Presentations...Herniated Nucleus Pulposus (HNP) . Mechanical Contributors to Cervical Spine Disorders . Definitions: - spondylo =

bor.rsbor.rs/wp-content/uploads/2016/07/2016-RESENJE-o-raspodeli-sredstava... · ru.1CT onu.JTL,1He Sop", ... AE-JIATHOCTVI AC MEAVIA, 3AJE-qAP Ha3HB MeAHja ... SERVIS VESTI NA YHanpehHBatba

bor.rsbor.rs/wp-content/uploads/2016/07/2016-RESENJE-o-raspodeli-sredstava... · ru.1CT onu.JTL,1He Sop", ... AE-JIATHOCTVI AC MEAVIA, 3AJE-qAP Ha3HB MeAHja ... SERVIS VESTI NA YHanpehHBatba

Valvular Heart Disease & New Treatment Options - CANPcanpweb.org/canp/assets/File/2013 Conference Presentations/CANP...Etiology • Valvular heart disease (VHD) accounts for 10-20%

Valvular Heart Disease & New Treatment Options - CANPcanpweb.org/canp/assets/File/2013 Conference Presentations/CANP...Etiology • Valvular heart disease (VHD) accounts for 10-20%

Defending PSA - CANP Conference/Presentations... · • Prostarix Post-Biopsy Biomarkers ... Systematic review of complications of prostate biopsy. European Urology, 64, 876-92. doi:

Defending PSA - CANP Conference/Presentations... · • Prostarix Post-Biopsy Biomarkers ... Systematic review of complications of prostate biopsy. European Urology, 64, 876-92. doi: